Market Overview

Regulus To Submit Comprehensive Data Package For RGLS4326 To FDA; Co. Previously Had Paused The Study Due To Unexpected Observations, No Adverse Or Other Significant Findings To Date

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: Biotech News Health Care FDA General

 

Related Articles (RGLS)

Lightning Fast
Market News Service
$199 Free 14 Day Trial

Class 8 Truck Orders Down In December, Up In 2018

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week